NIH clinical Drug trials
If you are in the process of learning about clinical trials or are considering participating in one, you may be interested in looking at Partners in Research (235 KB), which describes the role of a patient in clinical research. In addition, we encourage anyone with questions to call the Patient Recruitment Office at to try the "Topics A-Z" tool, an alphabetical index to all visitor- and patient-related subject areas.
- What are clinical studies?
Clinical studies are research studies in which real people participate as volunteers. Clinical research studies (sometimes called trials or protocols) are a means of developing new treatments and medications for diseases and conditions. There are strict rules for clinical trials, which are monitored by the National Institutes of Health and the U.S. Food and Drug Administration. Some of the research studies at the Clinical Center involve promising new treatments that may directly benefit patients.
- Why should I participate?
The health of millions has been improved because of advances in science and technology, and the willingness of thousands of individuals like you to take part in clinical research. The role of volunteer subjects as partners in clinical research is crucial in the quest for knowledge that will improve the health of future generations. Without your help, the research studies at the Clinical Center cannot be accomplished.
- Will I be compensated?
The NIH compensates study participants for their time and, in some instances, for the inconvenience of a procedure. There are standard compensation rates for the participant's time; the study's principal investigator determines inconvenience rates. NIH reports compensation of $600 or more to the Internal Revenue Service and sends a "Form 1099-Other Income" to the participant at the end of the year. Please be aware that some or all of that compensation may be garnished if the participant has outstanding debts to the federal government.
You might also like
Call to step up the pace of TB-HIV collaborative activities — Weekly Blitz
Discovery by biomedical research of new and improved interventions can get into the bucket of implementation.
What is the process for a drug that has entered clinical trials?
The NIH seems to be recruiting patients with malignant gliomas for phase I and phase II clinical trials.